Literature DB >> 28588678

Mechanism of N-acetyl-cysteine inhibition on the cytotoxicity induced by titanium dioxide nanoparticles in JB6 cells transfected with activator protein-1.

Hongbo Shi1,2, Yuanliang Gu1, Zhenhua Xie3, Qi Zhou1, Guochuan Mao1,2, Xialu Lin1, Kui Liu1, Yu Liu1, Baobo Zou1, Jinshun Zhao1.   

Abstract

The present study investigated the mechanism of N-acetyl-cysteine (NAC) inhibition on the cytotoxicity induced by titanium dioxide (TiO2) nanoparticles (NPs) using murine epidermal JB6 cells transfected with activator protein-1 (AP-1), JB6-AP-1 cells. Confocal microscopy was performed to localize TiO2 NPs in cultured cells. The level of reactive oxygen species (ROS) present in cells was evaluated by staining with 2',7'-dichlorodihydrofluorescein diacetate and dihydroethidium. AP-1 gene expression levels in the cells were detected using the luciferase assay. Confocal microscopy indicated that TiO2 NPs passed through the cell membrane into the cytoplasm; however, they did not penetrate the nuclear membrane. The present findings indicated that NAC markedly inhibited ROS generation and significantly inhibited cytotoxicity (P<0.05) induced by TiO2 NPs. Furthermore, alternative studies have demonstrated that AP-1 luciferase activity induced by TiO2 NPs may be significantly inhibited by NAC. In conclusion, the ability for NAC to inhibit the cytotoxicity induced by TiO2 NPs may primarily occur by blocking ROS generation in the cultured cells.

Entities:  

Keywords:  N-acetyl-cysteine; cytotoxicity; inhibition; reactive oxygen species; titanium dioxide nanoparticles

Year:  2017        PMID: 28588678      PMCID: PMC5450798          DOI: 10.3892/etm.2017.4415

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Nanoparticles (NPs) refer to ultrafine particles with diameter <100 nm (1). Due to their small size, the catalytic activity of NPs is increased (2). Titanium dioxide (TiO2) NPs possess various unique characteristics including superhydrophilic properties (3,4), energy absorption and lower transparency, which make them suitable for use in articulating prosthetic implants (5,6) sunscreens (7), biomedical fields, toothpaste (8) and textiles (9). Furthermore, previous results have supported the application of TiO2 NPs in advanced imaging technology and medical treatments (10). TiO2 NPs have wide applications and exposure of TiO2 NPs may cause direct or indirect adverse health effects on the human body (11). A previous study has demonstrated that exposure to TiO2 NPs results in an increase of reactive oxygen species (ROS) and glutathione levels in liver cells, accompanied by dose-dependent cytotoxicity (12). N-acetyl-cysteine (NAC) is a commonly used antioxidant that is used in toxicological research due to its beneficial properties, including water solubility and low toxicity (13,14). Furthermore, previous studies have demonstrated that NAC is able to prevent DNA mutations and suppress tumorigenesis (13). Additionally, previous results have demonstrated that ROS induced by zinc oxide NPs may be markedly scavenged by NAC (15). In clinical practice, NAC is used frequently as an antagonist to prevent traumatic brain injury promoted by inflammatory factors (16). In the present study, the underlying mechanism of NAC inhibition on the cytotoxicity induced by TiO2 NPs in JB6 cells transfected with activator protein-1 (AP-1) was investigated.

Materials and methods

Materials

TiO2 NPs (Lot No. 20110228) and fluorescein isothiocyanate (FITC)-labeled TiO2 NPs were purchased from Hangzhou Wanjing New Material Co., Ltd. (Hangzhou, China). Characteristics of the particles are listed in Table I. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS) and trypsin were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Hoechst 33,342, 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) and dihydroethidium (DHE) were purchased from Invitrogen (Thermo Fisher Scientific, Inc.). The luciferase assay kit was purchased from Promega Corporation (Madison, WI, USA).
Table I.

Characteristics of TiO2 NPs used in the present study.

NameCrystal formSurface featurePurity (%)Particle size (nm)Impurities (ppm)
TiO2 NPs100% AnataseHydrophilic  99.9940±5Pb, <2
Cd, <1
As, <1
Hg, <1
Ni, <1

TiO2 NPs, titanium dioxide nanoparticles; Pb, lead; Cd, cadmium; As, arsenic; Hg, mercury; Ni, Nickel.

TiO2 NP solution preparation

Stock solutions of TiO2 NPs were prepared by sonication on ice using a sonicator (Branson Ultrasonics, Slough, UK) in sterile PBS (10 mg/ml) for 30 sec. Prior to the experiment, the stock solution (1 µg/µl) was diluted to a desired concentration (0, 1, 5, 10, 15, 20 or 25 µg/ml) in fresh DMEM. All samples were prepared under sterile conditions.

Surface area and size distribution measurement

TiO2 NP size distribution was determined at room temperature using scanning electron microscopy (SEM; Hitachi S-4800; Hitachi, Ltd., Tokyo, Japan). TiO2 NPs were prepared by sonication and samples were diluted in double-distilled water (10 mg/ml). Subsequently, the samples were air-dried on a carbon planchet. Images were captured using SEM and Optimas 6.5 image analysis software (Meyer Instruments, Inc., Houston, TX, USA) was used to determine the diameter of the particles.

Cell culture

Mouse epidermal JB6 cells were obtained from the National Institute of Occupational Safety and Health (Washington, D.C., USA) and stably transfected with the AP-1 gene, as described previously (17), and cultured in DMEM supplemented with 5% FBS, 2 mM L-glutamine and 1% penicillin-streptomycin (10,000 U/ml penicillin and 10 mg/ml streptomycin) at standard culture conditions (37°C, 80% humidified air and 5% CO2). For all treatments, cells were grown to 80% confluency.

Localization of TiO2 NPs in culture cells

JB6-AP-1 cells were seeded in a 6-well plate (2.0×105 cells in 2 ml DMEM/well) and exposed to 10 µg/cm2 FITC-labeled TiO2 NPs for 12 h at 4°C. Following two washes for 30 sec with PBS, cells were fixed in 95% ethanol for 5 min at room temperature and stained with Hoechst 33342 dye buffer for 30 min. Following two washes with PBS, particle localization in the cells was observed using a confocal microscope (magnification, ×400) (Olympus Corporation, Tokyo, Japan).

ROS detection

H2DCFDA and DHE were used for staining general ROS and oxygen radicals in cells, respectively. Hoechst staining was performed as follows and used as a nucleic acid stain to indicate the nucleus. Cells treated without TiO2 NPs were used as a control, and H2O2 (200 µM) treated cells were used as a positive control. JB 6-AP-1 cells (2.0×105 cells in 2 ml DMEM/well) were seeded onto a slide that had been placed in a 6-well plate. Cultures were grown for 24 h in an incubator (37°C, 80% humidified air containing 5% CO2) and starved in DMEM supplemented with 0.1% FBS overnight. Subsequently, cells were treated with or without TiO2 NPs (25 µg/cm2) or TiO2 NPs plus 40 nM NAC or 200 µM H2O2 in the presence of H2DCFDA (5 µM), DHE (2 µM) and Hoechst 33342 (3 µM) for 1 h. Cells were washed for 30 sec three times with PBS and 0.1% of fresh FBS-DMEM was added. Phase contrast was ued and images were captured using a fluorescence microscope (magnification, ×400; LSM510; Zeiss, Germany).

MTT assay

Cell viability was assessed by the MTT assay. JB6-AP-1 cells were plated in 200 µl DMEM at a density of 104 cells/well in a 96-well plate. Following a 24-h incubation period at 37°C, cells were treated with varying concentrations (0, 1, 5, 15, 20 or 25 µg/cm2) of TiO2 NPs with or without 40 nM NAC in a phenolsulfonphthalein-free DMEM overnight (cells without any treatment were used as a control). Subsequently, cells were incubated with 10 µl MTT reagent for 4 h at 37°C. DMEM with the MTT reagent was discarded and 50 µl dimethyl sulfoxide was added. The optical density of each well was measured at a wavelength of 575 nm following shaking for 5 min.

Luciferase assay

JB6-AP-1 cells were seeded in a 24-well plate (0.5×105 cells in 0.5 ml/well) and incubated for 12 h (37°C in an 80% humidified atmosphere containing 5% CO2). Cells were starved in DMEM supplemented with 0.1% FBS overnight and subsequently exposed to different concentrations of TiO2 NPs (0, 1, 5, 10, 15, 20 or 25 µg/cm2) with or without 40 nM NAC for 12 h. Cells without any treatments were used as a control. Luciferase activity was measured using a luciferase assay kit according to the manufacturer's instructions.

Statistical analysis

Results were expressed as the mean ± standard deviation. Statistical differences were determined using SAS 9.1.3 software (SAS Institute, Inc., Cary, NC, USA). Multiple group comparisons of the data were performed using the one-way analysis of variance test. Dunnett's test was used to compare the difference between the experimental groups and the control group. P<0.05 was considered to indicate a statistically significant difference.

Results

The average size distribution of TiO2 NPs

The image of TiO2 NPs was captured using SEM (Fig. 1). The average TiO2 NP size distribution was 42.30±4.60 nm, which was detected by Optimas 6.5 image analysis software.
Figure 1.

A scanning electron microscope was used to capture an image of titanium dioxide nanoparticles.

Localization of TiO2 NPs in JB6-AP-1 cells

Following treatment with FITC-labeled TiO2 NPs, fluorescence microscopy was performed. Hoechst 33342 was used to stain the nucleus. The captured images indicated that the TiO2 NPs were localized in the cytoplasm and no TiO2 NPs were present in the nucleus, which was indicated by a nuclear shadow that demonstrated no FITC-fluorescence (Fig. 2).
Figure 2.

Localization of TiO2 NPs in JB6-AP-1 cells. (A) Image of JB6-AP-1 cell nuclei stained with Hoechst 33342 (blue). (B) Fluorescein isothiocyanate-labeled TiO2 NP staining (green dots) in JB6-AP-1 cells indicated localization of TiO2 NPs in the cytoplasm. (C) A and B images merged. TiO2 NPs, titanium dioxide nanoparticles. (magnification, ×400).

Following exposure with 25 µg/cm2 TiO2 NPs alone or 25 µg/cm2 TiO2 NPs plus 40 nM NAC, H2DCFDA and DHE dyes were used to detect the ROS and oxygen radical levels exhibited in JB6-AP-1 cells, respectively. Results indicated that NAC markedly inhibited ROS generation induced by TiO2 NPs compared with the control (Fig. 3).
Figure 3.

ROS detection. JB6-AP-1 cells were seeded onto a 24-well plate, incubated overnight and treated with 25 µg/cm2 TiO2 NPs with or without 40 nM NAC. The ROS generation was detected by H2DCFDA and DHE staining. Cell apoptosis was detected by Hoechst staining (magnification ×400). Phase contrast was used to locate the cells and images were merged to identify the position of ROSs in the nucleus and cytoplasm. ROS, reactive oxygen species; TiO2 NPs, titanium dioxide nanoparticles; NAC, N-acetyl-cysteine; H2DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate; DHE, dihydroethidium.

Cell viability

Following 24-h treatment with TiO2 NPs alone, the MTT assay results indicated that the cell viability was significantly suppressed when compared with cells that were also treated with NAC (P<0.05; Fig. 4). Furthermore, the present findings demonstrated that the addition of NAC significantly inhibited the cytotoxicity induced by TiO2 NPs in JB6-AP-1 cells (P<0.05; Fig. 4).
Figure 4.

Cytotoxicity induced by TiO2 NPs. The cell viability of JB6-AP-1 cells treated with varying concentrations (0, 1, 5, 15, 20 or 25 µg/cm2) of TiO2 NPs with or without 40 nM NAC was detected by the MTT assay. (A) Cell morphological changes were captured under a light microscope (magnification, ×400) and (B) the cell suppression ratio was calculated. Results indicated that cytotoxicity and cell apoptosis induced by TiO2 NPs was significantly inhibited. *P<0.05 vs. control. TiO2 NPs, titanium dioxide nanoparticles; NAC, N-acetyl-cysteine.

AP-1 gene expression levels

AP-1 luciferase activity was significantly upregulated when cells were treated with 5, 10, 15, 20 and 25 µg/cm2 of TiO2 NPs alone compared with cells treated with the same concentration of TiO2 NPs plus 40 nM NAC (P<0.05; Table II; Fig. 5). When cells were treated with 25 µg/cm2 TiO2 NPs, a reduced AP-1 luciferase activity level was exhibited when compared with cells treated with 20 µg/cm2 TiO2 NPs, which may be due to increased levels of apoptosis at this higher concentration (Table II, Fig. 5).
Table II.

Relative AP-1 luciferase activity.

Relative AP-1 luciferase activity

TiO2 NPs (µg/cm2)TiO2 NPs aloneTiO2 NPs plus 40 nM NAC
  04775.67±740.156341.00±106.93
  15052.67±811.585592.67±644.40
  56955.33±930.043759.33±111.89[b]
1036521.67±9788.71[a]3039.67±624.69[b]
1557157.00±9482.12[a]2809.67±732.57[b]
2075903.00±14334.71[a]2464.33±528.18[b]
2568298.67±8077.65[a]5114.33±1878.85[b]

Values are presented as mean ± standard deviation.

P<0.05 vs. 0 µg/cm2 TiO2 NPs

P<0.05 vs. TiO2 NPs treatment alone. AP-1, activator protein 1; TiO2 NPs, titanium dioxide nanoparticles; NAC, N-acetyl-cysteine.

Figure 5.

Relative AP-1 luciferase activity in JB6-AP-1 cells treated with varying concentrations (0, 1, 5, 10, 15, 20 or 25 µg/cm2) of TiO2 NPs with or without 40 nM NAC (cells without any treatments were used as a control). NAC (40 nM) significantly downregulated the relative AP-1 luciferase activity that was upregulated by TiO2 NPs. Data were analyzed using one-way analysis of variance. *P<0.05 vs. 0 µg/cm2 TiO2 NPs; #P<0.05 vs. TiO2 NPs alone. AP-1, activator protein-1; TiO2 NPs, titanium dioxide nanoparticles; NAC, N-acetyl-cysteine.

Discussion

Various types of NPs are under development for diagnostic and therapeutic applications in the biomedical field (18,19), yet knowledge about their possible toxicity in living cells remains limited (20). Furthermore, understanding on the prevention of NP toxicity in living cells is lacking. TiO2 NPs have an extensive application in the industrial, food, cosmetics and medicine sectors. Previous results have demonstrated that TiO2 NPs may be distributed in various organs and tissues in the body, following absorption through the gastrointestinal tract (21,22). In a previous study, it was demonstrated that TiO2 NPs induced apoptosis in cultured JB6 cells (23). To investigate the underlying mechanism of the inhibition of NAC on the cytotoxicity induced by TiO2 NPs, NP localization, ROS generation, cytotoxicity and AP-1 transcription factor regulation in JB6 cells transfected with the AP-1 gene treated with TiO2 NPs alone or TiO2 NPs plus NAC were evaluated in the present study. The present results demonstrated that TiO2 NPs, which were indicated to exhibit a mean core diameter of 42 nm, were transported into the cytoplasm once they had penetrated the cell membrane of JB6-AP-1 cells. No TiO2 NPs were identified in the cell nucleus, which was indicated by a clear nuclear shadow and no observed FITC-fluorescence. Halamoda Kenzaoui et al (20) reported that following uptake by human brain-derived endothelial cells, TiO2 NPs with a mean core diameter of 21 nm were transported into the lysosomes of these cells in the cytoplasm, which is in agreement with the present results. Gu et al (24) reported that gold NPs with an average diameter of 3.7 nm, which were modified with 3-mercaptopropionic acid and poly ethylene glycol, were able to penetrate into the nucleus of mammalian cells upon exposure for 24 h. Whether TiO2 NPs have the ability to penetrate into the nucleus remains to be confirmed. ROS are proposed to be associated with tumor metastasis, which is a complicated process involving migration, invasion of the tumor cells and angiogenesis (25). Generation of ROS is able to stimulate transcription by activating AP-1 and nuclear factor kappa B (26). Dhar et al (26) demonstrated that AP-1 activity abrogates transformation in JB6 cells, transgenic mice and human keratinocytes. Wang et al (27) revealed that TiO2 NPs exerted toxicity on murine spleen cells by promoting oxidative stress, which was indicated by the significantly increased levels of ROS in cells. Previous studies have suggested that oxidative stress may be induced by TiO2 NPs in A549 cells and rat lung alveolar macrophages (28,29). Gurr et al. (30) also reported that oxidative damage may be induced by TiO2 NPs in BEAS 2B cells. Antioxidants are typically used to reduce free radical formation (31). Xue et al (32) indicated that NAC is able to inhibit ROS formation in cells exposed to TiO2. Guo et al (33) observed in human umbilical vein endothelial cells that pretreatment with the free radical scavenger, NAC, inhibited the genotoxicity induced by multi-walled carbon nanotubes. Furthermore, in an in vivo study, El-Kirdasy et al (34) demonstrated the beneficial effect of NAC in preventing apoptosis in spermatogenic and sertoli cells, as well as alleviating testicular dysfunction induced by TiO2 NPs in male albino rats. In the present study, H2DCFDA and DHE were used for staining general ROS or oxygen radicals produced in JB6-AP-1 cells, respectively (35). The present results demonstrated that treatment with TiO2 NPs induced marked ROS generation in JB6-AP-1 cells. Fluorescence intensity indicated that treatment with NAC inhibited both general ROS and oxygen radical levels induced by TiO2 NPs and decreased the cytotoxicity of JB6-AP-1 cells. Furthermore, the luciferase assay revealed that NAC was able to downregulate AP-1 luciferase activity. These results suggest that the ability for NAC to inhibit the cytotoxicity induced by TiO2 NPs and downregulate the gene expression levels of AP-1 in JB6-AP-1 cells may occur predominantly due to ROS scavenging. Furthermore, the present results suggest that NAC may be a useful antioxidant in preventing induced carcinogenesis by TiO2 NPs. However, further in vivo studies are required to evaluate the effects of NAC in preventing induced toxicity by TiO2 NPs. In conclusion, the ability for NAC to inhibit cytotoxicity promoted by TiO2 NPs may occur primarily through ROS scavenging in JB6-AP-1 cells. NAC is able to inhibit general ROS and oxygen radicals, as well as downregulate the luciferase activity of AP-1 gene expression. In addition, the present study demonstrated that TiO2 NPs remained in the cytoplasm and did not penetrate the nuclear membrane.
  31 in total

1.  Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells.

Authors:  Blanka Halamoda Kenzaoui; Catherine Chapuis Bernasconi; Seher Guney-Ayra; Lucienne Juillerat-Jeanneret
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

2.  Cytotoxic and genotoxic effects of multi-wall carbon nanotubes on human umbilical vein endothelial cells in vitro.

Authors:  Yuan-Yuan Guo; Jun Zhang; Yi-Fan Zheng; Jun Yang; Xin-Qiang Zhu
Journal:  Mutat Res       Date:  2011-02-04       Impact factor: 2.433

3.  Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells.

Authors:  Jia-Ran Gurr; Alexander S S Wang; Chien-Hung Chen; Kun-Yan Jan
Journal:  Toxicology       Date:  2005-09-15       Impact factor: 4.221

4.  Titanium dioxide nanoparticles exhibit genotoxicity and impair DNA repair activity in A549 cells.

Authors:  Mary-Line Jugan; Sabrina Barillet; Angelique Simon-Deckers; Nathalie Herlin-Boime; Sylvie Sauvaigo; Thierry Douki; Marie Carriere
Journal:  Nanotoxicology       Date:  2011-10-13       Impact factor: 5.913

Review 5.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

6.  Titanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid and mitochondrial pathways.

Authors:  Jinshun Zhao; Linda Bowman; Xingdong Zhang; Val Vallyathan; Shih-Houng Young; Vincent Castranova; Min Ding
Journal:  J Toxicol Environ Health A       Date:  2009

7.  Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms.

Authors:  Agnes M Scherbart; Julia Langer; Alexey Bushmelev; Damien van Berlo; Petra Haberzettl; Frederik-Jan van Schooten; Annette M Schmidt; Christine R Rose; Roel P F Schins; Catrin Albrecht
Journal:  Part Fibre Toxicol       Date:  2011-10-13       Impact factor: 9.400

8.  Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia.

Authors:  Shih-Hsiang Liao; Chia-Hung Liu; Bishnu Prasad Bastakoti; Norihiro Suzuki; Yung Chang; Yusuke Yamauchi; Feng-Huei Lin; Kevin C-W Wu
Journal:  Int J Nanomedicine       Date:  2015-05-04

Review 9.  Toxic effects of the interaction of titanium dioxide nanoparticles with chemicals or physical factors.

Authors:  Kui Liu; Xialu Lin; Jinshun Zhao
Journal:  Int J Nanomedicine       Date:  2013-07-18

10.  Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice.

Authors:  Jiaying Xu; Hongbo Shi; Magaye Ruth; Hongsheng Yu; Lissy Lazar; Baobo Zou; Cui Yang; Aiguo Wu; Jinshun Zhao
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.